Area of Focus | Biotechnology & Pharmaceutical

MOVING FORWARD
WITH TECHNOLOGY

BioPharma Brochure
Biotechnology & Pharmaceutical

Experience is key. With outstanding educational and professional credentials in the life sciences and global experience in IP law, Brinks attorneys provide sophisticated IP services and solutions in areas including Hatch-Waxman litigation, pharmaceutical and biological client counseling, trademark analysis, pharmaceutical patent prosecution, and patent portfolio management.

Our clients range from start-ups and entrepreneurs to multinational corporations; from academic institutions to investors in technology. We bring our diverse experience, thought processes and backgrounds together so we can appreciate and address all of our clients’ concerns. Further setting us apart:

  • Our Team: Our experienced attorneys and patent agents in the biotechnology and pharmaceutical space have exceptional advanced qualifications, including Ph.D. and Master’s degrees.
  • Our History: Established more than 100 years ago, Brinks has a solid history of providing highly effective legal services and obtaining IP rights for our clients that withstand the test of time.
  • Our Reputation: Brinks attorneys are frequently recognized for their excellence and professionalism in the legal industry.
  • Our Insight: With deep knowledge of and decades of experience in the industry, Brinks attorneys understand in detail our clients’ complex problems, and offer effective, holistic solutions.

With increasing costs and regulations, the biotechnology and pharmaceutical industry is never standing still. Despite rapid changes and sharp learning curves, our attorneys are dedicated to building strategic partnerships with our clients so they will continuously succeed.

Meet our team.

Forward Thinking
Exclusivity for Biologic Products Under the USMCA: What Is Changing, and What Happens Next?
August 15, 2019
Twelve Attorneys at IP Law Firm Brinks Gilson & Lione Recognized in The Best Lawyers in America 2020
August 15, 2019
Brinks Gilson & Lione's New Shareholders
June 13, 2019
Federal Circuit: Written Description of Claimed Result Requires More Than Recitation of Claim Language
June 12, 2019
USPTO Issues Examination Guide on Trademark Applications for Cannabis and Cannabis-Related Goods and Services
June 11, 2019
Congress Rethinking Patent Eligibility
May 31, 2019
Marketing authorisation: Splitting the bill
May 20, 2019
Brinks Shareholder Mark Remus is Quoted in Law360
April 03, 2019
Brinks Counsel Kent Walker is Quoted in The Pharma Letter
March 08, 2019
Brinks Counsel Kent Walker is Quoted in Pink Sheet
February 13, 2019
Shareholder Mark Remus is Quoted in Westlaw Journal Intellectual Property
January 30, 2019
Shareholder Mark Remus is Quoted in IPPRo Magazine
January 24, 2019
Shareholder Mark Remus is Quoted in Intellectual Property Magazine
January 23, 2019
Shareholder Mark Remus is Quoted in Law360
January 22, 2019
Westlaw Journal Intellectual Property Quotes Brinks Shareholder Mark Remus
12/19/2018
PTAB Same Party Joinder Goes POP!
December 11, 2018
Brinks Gilson & Lione's Ney Receives Up & Coming Lawyer Honor from Michigan Lawyers Weekly
December 11, 2018
IPPro Magazine Quotes Brinks Shareholder Mark Remus
December 05, 2018
Law360 Quotes Brinks Shareholder Mark Remus
December 03, 2018
Is an Indemnifying Supplier an IPR Petitioner
November 14, 2018
Defining "Person" in the AIA: SCOTUS Grants Cert in Return Mail, Inc. v. United States Postal Service, et al.
November 12, 2018
U.S. News & World Report Recognizes IP Law Firm Brinks Gilson & Lione Seventeen Times in 2019 "Best Law Firms" List
November 09, 2018
A Tune of Modernity: The Music Modernization Act
October 17, 2018
Two New Weapons for Defending Hatch-Waxman Litigation
September 03, 2018
Fourteen Attorneys at IP Law Firm Brinks Gilson & Lione Recognized in The Best Lawyers in America 2019
August 15, 2018
En Banc Federal Circuit Bars USPTO's Recovery of Attorney Fees in ยง145 District Court Actions - Nantkwest, Inc. v. Iancu, No. 2016-1794 (Fed. Cir. July 27, 2018)(en banc)
August 07, 2018
Federal Circuit Rejects Tribal Sovereign Immunity Defense in IPR Proceedings
July 24, 2018
TROL Act Seeks to Protect Businesses from Abusive Patent Demand Letters
July 23, 2018
Counsel Kent Walker Speaks To Law360
June 20, 2018
Trademark Enforcement Implications of Europe's New General Data Protection Regulation (GDPR)
June 05, 2018
The Expanded Scope of the Printed Matter Doctrine and Effect on "Mental Steps"
May 30, 2018
Federal Circuit Rules That Foreign Defendants Cannot Rely On 28 U.S.C. ยง 1400(b) To Challenge Venue
May 14, 2018
PTAB Provides Guidance On The Impact Of SAS On AIA Trial Proceedings
April 27, 2018
Supreme Court Signals Full Steam Ahead for Challenging Patents in AIA Proceedings in Back-to-Back Oil States and SAS Institute Decisions
April 25, 2018
The Carvedilol District Court Case
April 12, 2018
Brinks Gilson & Lione Expands Biopharma Practice
April 09, 2018
USTR Identifies Action Under Section 301 and Proposed List of Products Subject to Increased Tariffs
April 04, 2018
Recent Decisions In Favor Of Patent Eligibility Focus On Factual Inquiries
March 19, 2018
Cornerstone To An International Intellectual Property Protection Center
March 05, 2018
Subject Matter Eligibility and Questions of Fact
February 22, 2018
In re Hodges, Appeal No. 2017-1434 (Fed. Cir. 2018)
February 15, 2018
Brinks Webinar | 2018 IP Developments
February 07, 2018
Brinks Webinar | 2018 IP Developments
February 07, 2018
Are Foreign Lost Profits Really Lost?
January 25, 2018
Janssen Biotech Unable To Rewrite History and Save Remicade Patent
January 25, 2018
PTAB Denies Request for Institution of Post-Grant Review in "Live Nation Entertainment" Case
January 25, 2018
Time to Appeal: Challenging PTAB Time-Bar Determinations at the Federal Circuit
January 16, 2018
Modernizing Digital Licensing: Introducing the Music Modernization Act
January 03, 2018
Travel Sentry, Inc. v. Tropp: Federal Circuit Revisits Direct-infringement Liability for Third-party Conduct
January 03, 2018
In re Brunetti: Toppling the Bar on Bad Words
December 21, 2017
BPCIA Preempts State Law Remedies for Biosimilar Applicant's Refusal to Disclose Abbreviated Biologics License Application
December 18, 2017
New USPTO Mega-Sequence Listing Fees
December 04, 2017
U.S. Supreme Court Hears "Oil States" Oral Arguments Regarding Constitutionality of the Patent Office Review Board
November 29, 2017
Federal Circuit Ruling Makes It Possible To Move For A Change In Venue Even In Patent Infringement Cases In Which The Deadline For Such Motions Previously Had Passed
November 16, 2017
Brinks Webinar | Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings
November 09, 2017
Attorneys To Address Issues Affecting PTAB Proceedings for Biopharmaceutical and Medical Device Innovations
November 01, 2017
U.S. News & World Report and Best Lawyers Recognize IP Law Firm Brinks Gilson & Lione Seventeen Times in 2018 "Best Law Firms" List
November 01, 2017
Federal Circuit Says "Teaching Away" Must Cover the Entire Claim Scope
October 23, 2017
Aqua Products, Inc. v. Matal: En Banc Decision on Motions to Amend Claims in AIA Post-Grant Proceedings Issues
October 06, 2017
Federal Circuit Upholds District Court Vacatur of Jury Verdict Under Doctrine of Equivalents Based Upon Ensnarement Defense
October 04, 2017
It Pays to be Persistent if PTAB Rulings Violate Due Process Ultratec v. CaptionCall and Matal (Fed. Cir. 2017)
September 06, 2017
Fifteen Attorneys at IP Law Firm Brinks Gilson & Lione Recognized in The Best Lawyers in America 2018, Three Named "Lawyer of the Year"
August 15, 2017
What To Expect in the Future with the STRONGER Patents Act of 2017
July 31, 2017
Paying for Attorneys' Fees Whether you Win or Lose on Appeals from the PTAB
June 28, 2017
The Federal Circuit Gives Patent Owners A Fighting Chance: Due Process In IPR Proceedings
June 26, 2017
Federal Circuit Concludes Differently on Two Exceptional Case Actions
June 12, 2017
Supreme Court Alters the Landscape of Venue for Patent Infringement Litigation
May 23, 2017
Federal Circuit Maintains Pre-AIA Interpretation of the On-Sale Bar for Public Sales
May 16, 2017
Brinks Gilson & Lione Litigators Ralph Gabric, Laura Lydigsen Present at ACI Paragraph IV Disputes Conference
April 21, 2017
USPTO Seeking Potential Reforms to PTAB Proceedings
April 14, 2017
Federal Circuit Confirms Judicial Review On PTAB's CBM Institution
April 07, 2017
U.S. Supreme Court Hears TC Heartland Case
March 28, 2017
SCA Hygiene v. First Quality Baby Products: Laches Defense Limited in Patent Infringement Cases
March 22, 2017
New Amendments to SIPO's Guidelines for Patent Examination
March 16, 2017
Mark Remus Mentioned in Chicago Daily Law Bulletin
March 14, 2017
Patent Litigator Mark Remus Presents on IPR Strategy at CPhI's 6th Annual Pharma IPR Conference
March 07, 2017
Mark Remus to Present at CPhI's 6th Annual Pharma IPR Conference
March 01, 2017
Jeff Nichols to Present at ACI's 15th Advanced Summit on Life Sciences Patents
February 28, 2017
Managing Patent Portfolios and Drafting Applications To Withstand IPR Challenges
February 10, 2017
Brinks Gilson & Lione Shareholder Jeff Nichols Presents on IPR Best Practices at ACI Life Sciences Patent Summit
February 02, 2017
Update on CRISPR Patent Battle
January 10, 2017
USTR Requests Comments in its Annual "Special 301" Review of Countries that Deny Adequate and Effective Protection of Intellectual Property Rights and Fair Market Access
January 04, 2017
New DMCA Registration Requirements
December 07, 2016
Supreme Court Upsets the Design-Patent Damages Apple Cart โ€“ Remands to Federal Circuit
December 07, 2016
U.S. Supreme Court to Review the Judicial Doctrine of Patent Exhaustion
December 07, 2016
Brinks Webinar | The Patent Prosecution Highway
November 14, 2016
Brinks Gilson & Lione Shareholder Rashad Morgan Joins The Fellows of the American Bar Foundation
November 07, 2016
Brinks Webinar | Understanding Patent Examiner Docketing & Workflow to Expedite Prosecution
October 25, 2016
When Your Export Business Suddenly Becomes Substantial: Are Your Export Commodities Substantial Enough To Induce Infringement Under ยง271(f)(1) of the Patent Act?
September 26, 2016
Fifteen Attorneys at Intellectual Property Law Firm Brinks Gilson & Lione Listed in the The Best Lawyers in America 2017
August 15, 2016
The Ultimate Burden of Proof Remains with Petitioner Throughout an Inter Partes Review
August 01, 2016
Post Prosecution Pilot Program (P3)
July 21, 2016
Brexit's Impact on Intellectual Property Rights in the United Kingdom
July 14, 2016
Biosimilar Product Notice
July 13, 2016
Further Clarity For the On-Sale Bar
July 12, 2016
Method for New and Useful Laboratory Technique Involving Law of Nature is Patent-Eligible
July 12, 2016
Brinks Gilson & Lione IP Litigator Fernandez Named to Florida Legal Elite 2016
June 28, 2016
Federal Circuit Upholds Same-Day Continuations
June 27, 2016
Brinks Attorneys Discuss PTAB Decision in IP Frontline
June 17, 2016
Never Late Is Better: PTAB Denies Petitioners Motion In IPR After Missing Filing Deadline By Minutes
June 14, 2016
Cuozzo Speed Technologies, LLC v. Lee
April 28, 2016
Amendment or Abolition of 35 U.S.C. ยง 101
April 15, 2016
Process Limitations Are Not Relevant to the Validity of Pharmaceutical Product Claims
February 05, 2016
Brinks 2016 IP Developments Webinar
January 28, 2016
Intellectual Property Law Firm Brinks Gilson & Lione to Address Recent Developments in IP Law
January 25, 2016
Supreme Court to Hear Claim Construction Case
January 20, 2016
Intellectual Property Attorneys Jennifer Fox and Rashad Morgan Elected Shareholders at Brinks Gilson & Lione in Research Triangle Park
January 19, 2016
Federal Circuit Hears Arguments in Hatch-Waxman Personal Jurisdiction Challenge: Mylan Argues Brands Should Sue Them in West Virginia
January 15, 2016
Brinks attorneys named Leading Lawyers in Michigan for 2015-2016
December 29, 2015
U.S News & World Report and Best Lawyers Again Rank Brinks Gilson & Lione Highest in Patent, Trademark Law for 2016
December 10, 2015
Coalition for Affordable Drugs Not Sanctioned by the PTAB
October 05, 2015
Coalition for Affordable Drugs
September 11, 2015
Patent Litigator Mark Remus Rejoins National Intellectual Property Law Firm Brinks Gilson & Lione
September 01, 2015
Federal Circuit Interprets Key Provisions Governing Biosimilars
July 21, 2015
Legal 500 Names Brinks a Top U.S. Firm for Utility and Design Patent Prosecution for Seventh Consecutive Year
July 07, 2015
Federal Circuit Rules that a Patentee Cannot Seek Safe Harbor Protection by Rewriting History
July 01, 2015
The Federal Circuit Deals Another Setback to Medical Diagnostic Patents
June 15, 2015
Managing IP Names Nine Brinks Attorneys to IP Stars for 2015, Recommends Firm's Illinois, Michigan, and North Carolina Offices
June 01, 2015
Fed. Cir. Confirms § 271(e)(1) Safe Harbor Applies to Post-Approval Development of Clinical Data for Citizen Petition and Supplemental New Drug Application
May 22, 2015
Vague Drug Label Instructing Physician Consultation is Insufficient to Find Induced Infringement
May 12, 2015
The Federal Circuit Limits the Use of the Patent Exhaustion Defense to "Authorized Acquirers"
March 13, 2015
First-Ever Biosimilar Application Approved by FDA Under BPCIA
March 09, 2015
Patent Term Extension Under 35 U.S.C. ยง156
March 03, 2015
PTAB Sides with Petitioner in Pharmaceutical Inter Partes Reviews
March 03, 2015
U.S. Supreme Court Decides in Teva v. Sandoz That "Evidentiary Underpinnings" to Claim Construction Are Reviewed for Clear Error
January 21, 2015
The Effect of Daimler AG v. Bauman on Personal Jurisdiction in Hatch-Waxman Lawsuits
January 20, 2015
USPTO Issues Revised Guidelines For Patent Eligibility
January 08, 2015
Jury Sides with Drug Makers in Alleged Pay-for-Delay Trial
December 09, 2014
Federal Circuit Denies En Banc Rehearing for Hepatitis Drug Patent Ruling
October 27, 2014
Federal Court of Australia declined to follow U.S. Supreme Court in Myriad
10/21/2014
Does an Off-label, Non-Infringing Use of a Drug Constitute a "Substantial Non-Infringing" Use Sufficient to Defeat a Claim for Contributory Patent Infringement?
September 15, 2014
Fed. Circ. And USPTO Diverge On Lead Compound Analysis
July 30, 2014
Federal Circuit Rules that Dolly the Cloned Sheep is not Patentable
May 13, 2014
USPTO Issues New Patent Subject Matter Eligibility Guidelines under Myriad and Mayo Decisions
March 24, 2014
Supreme Court Rules that "Reverse Payment" Settlement Agreements are not Presumptively Unlawful but may be Challenged Under Antitrust Laws
June 18, 2013
Supreme Court Strikes Down Patents on Isolated DNA
June 13, 2013
Supreme Court Issues Narrow Ruling Regarding the Doctrine of Patent Exhaustion and Genetically Modified Seeds
May 17, 2013
How to Protect Inventions Under New Novelty Statute
September 20, 2012
Brinks 2012 - Innovation Begins Here
January 2012
Patent Validity Challenges in the Medical Device and Diagnostic Industry
November 16, 2011
Patent Validity Challenges in the Medical Device and Diagnostic Industry
October 27, 2011
Lessons from Stanford
August 23, 2011
Q&A With Brinks Hofer's Gary Ropski
October 05, 2007
When Is Private Really Public?
June 01, 2006
The Pre-Clinical Research Statutory Infringement Exemption
October 2005
Practitioners Be Wary: The Dangers of Functional Descriptions in Biotech Inventions
August 19, 2003
Forward Thinkers
View All
Group Chairs
Jeff Nichols
Contact
Shareholder
Chicago, IL
312.245.5393
Group Chairs

We collect certain information to enhance your browsing experience. By using our website, you agree with this practice.

For more information, please see our Privacy Statement.